Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Transactions
Holdings
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
CC transcript
IONIS PHARMACEUTICALS INC (IONS) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/12/2023 144 Form 144 - Report of proposed sale of securities:
10/12/2023 144/A Form 144/A - Report of proposed sale of securities: [Amend]
09/29/2023 144 Form 144 - Report of proposed sale of securities:
09/27/2023 8-K Quarterly results
09/26/2023 144 Form 144 - Report of proposed sale of securities:
09/26/2023 144 Form 144 - Report of proposed sale of securities:
08/23/2023 8-K Other Events  Interactive Data
08/14/2023 144/A Form 144/A - Report of proposed sale of securities: [Amend]
08/10/2023 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
08/09/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/09/2023 8-K Quarterly results
Docs: "CARLSBAD, Calif., August 9, 2023"
08/04/2023 8-K Termination of a Material Definitive Agreement  Interactive Data
08/03/2023 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits  Interactive Data
Docs: "CARLSBAD, Calif., –"
08/02/2023 144 Form 144 - Report of proposed sale of securities:
07/19/2023 144 Form 144 - Report of proposed sale of securities:
07/10/2023 8-K Quarterly results
07/07/2023 144 Form 144 - Report of proposed sale of securities:
06/12/2023 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs: "SECURITIES AND EXCHANGE COMMISSION",
"Indenture, by and between the Company and U.S. Bank Trust Company, National Association, as Trustee",
"Ionis prices private placement of convertible senior notes"
06/09/2023 SC 13G/A VANGUARD GROUP INC reports a 10.1% stake in Ionis Pharmaceuticals Inc.
06/06/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "SECURITIES AND EXCHANGE COMMISSION",
"Ionis announces proposed private placement of convertible notes",
"Excerpts from Confidential Preliminary Offering Memorandum"
05/24/2023 144 Form 144 - Report of proposed sale of securities:
05/23/2023 144 Form 144 - Report of proposed sale of securities:
05/03/2023 10-Q Quarterly Report for the period ended March 31, 2023
05/03/2023 8-K Quarterly results
Docs: "Ionis reports first quarter 2023 financial results"
04/24/2023 8-K Quarterly results
04/20/2023 ARS Form ARS - Annual Report to Security Holders:
04/20/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
04/20/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
04/17/2023 144 Form 144 - Report of proposed sale of securities:
04/17/2023 144 Form 144 - Report of proposed sale of securities:
04/17/2023 144 Form 144 - Report of proposed sale of securities:
03/27/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Ionis reports positive topline 66-week results of eplontersen Phase 3 study for patients with ATTRv-PN"
02/22/2023 10-K Annual Report for the period ended December 31, 2022
02/22/2023 8-K Quarterly results
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy